Safety, Reactogenicity, Immunogenicity, and Efficacy of Quadrivalent Inactivated Subunit Influenza Vaccine Grippol ® Quadri and Trivalent Inactivated Polymer-Subunit Vaccine Grippol® Plus in Volunteers
Condition: Influenza Interventions: Biological: Grippol® Quadri; Biological: Grippol® Plus, trivalent (Yamagata lineage); Biological: Grippol® Plus, trivalent (Victoria lineage) Sponsor: NPO Petrovax Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials